+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Medicine Software Market by Type (EHR Integration, Genomic Data Analysis, Patient Satisfaction & Risk Assessment), Application (Cardiology, Neurology, Oncology), Deployment Mode, End User - Global Forecast 2025-2030- Product Image
Personalized Medicine Software Market by Type (EHR Integration, Genomic Data Analysis, Patient Satisfaction & Risk Assessment), Application (Cardiology, Neurology, Oncology), Deployment Mode, End User - Global Forecast 2025-2030- Product Image
Sale

Personalized Medicine Software Market by Type (EHR Integration, Genomic Data Analysis, Patient Satisfaction & Risk Assessment), Application (Cardiology, Neurology, Oncology), Deployment Mode, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090202
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Personalized Medicine Software Market grew from USD 2.27 billion in 2024 to USD 2.51 billion in 2025. It is expected to continue growing at a CAGR of 10.91%, reaching USD 4.23 billion by 2030.

Setting the Stage for Personalized Medicine Software with Emerging Opportunities and Core Industry Dynamics Shaping Precision Healthcare

Personalized medicine software is rapidly redefining how healthcare providers, research institutes, and technology innovators collaborate to deliver precision care tailored to individual patient profiles. In this evolving landscape, data integration and advanced analytics converge to transform clinical decision making, bridging the gap between complex genomic datasets and everyday care pathways. As stakeholders navigate interoperability challenges, regulatory requirements, and rising expectations for patient-centric outcomes, the imperative for agile, scalable software solutions has never been greater.

The introduction of sophisticated algorithms and integration platforms is ushering in an era where diagnostic insights, risk stratification, and treatment recommendations can be delivered with unprecedented accuracy and speed. Collaboration among clinicians, data scientists, and software developers is key to unlocking the potential of these tools, enabling seamless workflows that enhance patient satisfaction and clinical efficiency. As digital transformation accelerates across the healthcare sector, understanding the foundational dynamics of this software ecosystem is critical for decision leaders seeking to align investments with long-term growth trajectories.

Unraveling the Transformative Forces Reinventing Personalized Medicine Software to Accelerate Data-Driven Precision Care

As the personalized medicine software sector matures, a series of transformative shifts are reshaping its trajectory, driving more robust collaboration between life sciences and digital health pioneers. Artificial intelligence and machine learning engines now power predictive models that anticipate disease progression, while advanced analytics platforms facilitate real-time integration of electronic health records with genomic data. Consequently, the transition from reactive to proactive care pathways is reshaping value propositions for both providers and patients.

Moreover, regulatory frameworks are evolving to accommodate digital biomarkers and algorithm-driven diagnostics, nudging vendors to adopt transparent data governance and explainable AI practices. Patient engagement portals and risk assessment tools have become integral for enhancing adherence and clinical outcomes, further reinforcing the shift toward holistic patient management. As interoperability standards gain momentum, the ability to harmonize decentralized data sources will become a critical differentiator, setting the stage for next-generation solutions that deliver end-to-end clinical intelligence.

Evaluating the Comprehensive Consequences of United States Tariffs on Personalized Medicine Software Supply Chains and Market Accessibility in 2025

The imposition of United States tariffs in 2025 has introduced a complex array of cost pressures and strategic considerations for stakeholders in the personalized medicine software ecosystem. Software development firms that rely on imported hardware components for on-premises deployments have faced elevated procurement expenses, prompting a reexamination of sourcing strategies and supplier partnerships. Consequently, some innovators have accelerated investments in domestic manufacturing capabilities or embraced licensing models that bundle software with locally sourced appliances.

In addition to direct hardware cost escalations, cross-border licensing agreements and cloud service contracts have been affected by evolving trade regulations. This has led to enhanced diligence around contract terms and an increasing preference for flexible deployment options that hedge against future tariff volatility. As vendors and end users navigate these headwinds, collaborative frameworks for shared infrastructure and regional data centers have emerged as adaptive solutions, ensuring continuity of service delivery while managing total cost of ownership.

Deciphering Critical Segmentation Dimensions to Unlock Targeted Strategies Across Technology Types Applications Deployment Models and End Users

Insights derived from analyzing the market across Type reveal a dynamic mix of functionalities encompassing electronic health record integration, comprehensive genomic data analysis, patient satisfaction and risk assessment modules, predictive analytics engines, and treatment recommendation platforms. Across Application segments, the software demonstrates distinct capabilities tailored to cardiology, neurology, and oncology use cases, each driven by unique clinical workflows and data complexity. Deployment models further underscore the choice between cloud-based solutions that deliver rapid scalability and on-premises systems preferred by organizations prioritizing data sovereignty and stringent security protocols. Finally, examining End User categories highlights divergent adoption trends: healthcare providers, including both clinics and hospitals, increasingly leverage integrated platforms to streamline patient journeys, while research institutes-spanning academic institutions and independent laboratories-prioritize specialized analytics tools to accelerate translational research and clinical trials.

Uncovering Regional Dynamics and Growth Drivers Influencing Personalized Medicine Software Adoption Across the Americas EMEA and Asia-Pacific

Regional dynamics play a pivotal role in shaping personalized medicine software adoption and innovation pathways. In the Americas, strong R&D ecosystems and favorable reimbursement policies have catalyzed the deployment of advanced analytics and precision diagnostics, while regional centers of excellence drive collaboration between academic hospitals and technology startups. Within Europe, Middle East and Africa, regulatory harmonization initiatives such as unified data protection frameworks have fostered cross-border partnerships, enabling vendors to introduce scalable solutions that meet diverse compliance requirements. Meanwhile, the Asia-Pacific region stands out for its rapid digital health infrastructure expansion and government-sponsored genomics initiatives, which together are accelerating demand for integrated platforms designed to manage large-scale population health studies and emerging clinical applications.

Profiling Leading Innovators Shaping the Personalized Medicine Software Landscape Through Technology Leadership and Collaborative Ecosystem Partnerships

Leading technology firms and specialized innovators are at the forefront of personalized medicine software development, each advancing unique value propositions that span core platform capabilities and niche application modules. Established enterprise software providers are leveraging broad interoperability networks and extensive clinical partnerships to deliver end-to-end solutions, while genomic analysis specialists are introducing cutting-edge sequencing interpretation engines that enhance diagnostic accuracy. Additionally, agile startups focused on predictive modeling are gaining traction by offering modular architectures that integrate seamlessly into existing clinical workflows. Strategic collaborations between healthcare systems and research organizations further enrich the competitive landscape, enabling co-development of bespoke solutions tailored to emerging therapeutic areas and precision treatment protocols.

Strategic Imperatives for Industry Pioneers to Harness Personalized Medicine Software Innovations and Sustain Competitive Resilience

Industry leaders should prioritize a multifaceted strategy to capitalize on evolving market dynamics. First, deepening interoperability standards across electronic health record systems and genomic repositories will ensure seamless data exchange and foster broader adoption. Secondly, investing in robust data privacy frameworks and compliant deployment options can differentiate offerings in regions with stringent regulatory oversight. Organizations should also cultivate strategic alliances with hardware manufacturers and cloud service providers to mitigate tariff impacts and optimize total cost structures. Furthermore, expanding domain expertise in high-growth therapeutic segments-such as neurology and oncology-will unlock new revenue streams, while tailored service models for hospitals, clinics, academic centers, and independent labs will enhance market penetration. Lastly, continuous horizon scanning for emerging technologies and regulatory shifts will enable proactive roadmap adjustments and sustain competitive resilience.

Explaining the Rigorous Multimodal Research Methodology Employed to Generate Comprehensive and Objective Insights on Personalized Medicine Software

The research methodology underpinning this analysis integrates multimodal data collection and rigorous validation protocols to ensure comprehensive and objective insights. Primary interviews with clinicians, health system executives, software architects, and research scientists provided qualitative perspectives on real-world challenges and solution priorities. A systematic review of peer-reviewed publications, regulatory filings, and industry white papers supplemented these insights with objective evidence. Quantitative data was triangulated using proprietary patent analytics, technology adoption metrics, and public financial disclosures. The segmentation framework was developed through iterative workshops with domain experts, and scenario modeling was employed to assess the potential impact of tariff changes, regulatory shifts, and regional policy initiatives. Each finding was peer reviewed by an advisory panel of healthcare and data science specialists to ensure accuracy and relevance.

Synthesizing Core Findings and Future Outlook for Personalized Medicine Software to Guide Stakeholder Decision Making and Strategic Roadmaps

This executive summary synthesizes the core findings required to navigate the personalized medicine software landscape, from foundational market dynamics and transformative forces to targeted segmentation and regional growth drivers. It underscores the importance of interoperability, flexible deployment strategies, and targeted therapeutic focus areas in driving adoption and optimizing clinical outcomes. By integrating tariff impact analyses and strategic company profiles, stakeholders can confidently align their investments with emerging opportunities. Ultimately, sustained innovation, collaborative partnerships, and proactive adaptation to regulatory and trade environments will determine long-term success in delivering precision care solutions that meet the evolving needs of providers and patients alike.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • EHR Integration
    • Genomic Data Analysis
    • Patient Satisfaction & Risk Assessment
    • Predictive Analysis
    • Treatment Recommendation Engine
  • Application
    • Cardiology
    • Neurology
    • Oncology
  • Deployment Mode
    • On-cloud
    • On-premises
  • End User
    • Healthcare Providers
      • Clinics
      • Hospitals
    • Research Institutes
      • Academic Institutes
      • Independent Labs
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • 23andMe, Inc.
  • 3D Systems, Inc.
  • Caris Life Sciences, Inc.
  • Epic Systems Corporation
  • Flatiron Health, Inc.
  • Foundation Medicine, Inc.
  • Genelex Corporation
  • Genomind, Inc.
  • Health Fidelity, Inc.
  • IBM Corporation
  • Illumina, Inc.
  • Innowise
  • Invitae Corporation
  • NantHealth, Inc.
  • OSP Labs
  • Personal Genome Diagnostics, Inc.
  • Roche Holding AG
  • Strand Life Sciences Pvt. Ltd.
  • Syapse, Inc.
  • Tempus AI, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multi-omics data analytics algorithms for precision therapy selection in oncology patients
5.2. Deployment of AI-driven digital twin models to predict individualized drug response and dosing regimens
5.3. Development of cloud-native personalized medicine platforms with robust data privacy and security controls
5.4. Adoption of patient-derived organoid screening software to tailor treatment plans in rare genetic disorders
5.5. Implementation of federated learning frameworks for cross-institutional genomic data sharing without data centralization
5.6. Utilization of real-world evidence and wearable device data ingestion for dynamic therapy adjustment in chronic diseases
5.7. Expansion of pharmacogenomics decision support tools within electronic health record systems for clinical workflows
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Personalized Medicine Software Market, by Type
8.1. Introduction
8.2. EHR Integration
8.3. Genomic Data Analysis
8.4. Patient Satisfaction & Risk Assessment
8.5. Predictive Analysis
8.6. Treatment Recommendation Engine
9. Personalized Medicine Software Market, by Application
9.1. Introduction
9.2. Cardiology
9.3. Neurology
9.4. Oncology
10. Personalized Medicine Software Market, by Deployment Mode
10.1. Introduction
10.2. On-cloud
10.3. On-premises
11. Personalized Medicine Software Market, by End User
11.1. Introduction
11.2. Healthcare Providers
11.2.1. Clinics
11.2.2. Hospitals
11.3. Research Institutes
11.3.1. Academic Institutes
11.3.2. Independent Labs
12. Americas Personalized Medicine Software Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Personalized Medicine Software Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Personalized Medicine Software Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 23andMe, Inc.
15.3.2. 3D Systems, Inc.
15.3.3. Caris Life Sciences, Inc.
15.3.4. Epic Systems Corporation
15.3.5. Flatiron Health, Inc.
15.3.6. Foundation Medicine, Inc.
15.3.7. Genelex Corporation
15.3.8. Genomind, Inc.
15.3.9. Health Fidelity, Inc.
15.3.10. IBM Corporation
15.3.11. Illumina, Inc.
15.3.12. Innowise
15.3.13. Invitae Corporation
15.3.14. NantHealth, Inc.
15.3.15. OSP Labs
15.3.16. Personal Genome Diagnostics, Inc.
15.3.17. Roche Holding AG
15.3.18. Strand Life Sciences Pvt. Ltd.
15.3.19. Syapse, Inc.
15.3.20. Tempus AI, Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. PERSONALIZED MEDICINE SOFTWARE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PERSONALIZED MEDICINE SOFTWARE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PERSONALIZED MEDICINE SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PERSONALIZED MEDICINE SOFTWARE MARKET: RESEARCHAI
FIGURE 24. PERSONALIZED MEDICINE SOFTWARE MARKET: RESEARCHSTATISTICS
FIGURE 25. PERSONALIZED MEDICINE SOFTWARE MARKET: RESEARCHCONTACTS
FIGURE 26. PERSONALIZED MEDICINE SOFTWARE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PERSONALIZED MEDICINE SOFTWARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY EHR INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY EHR INTEGRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY GENOMIC DATA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY GENOMIC DATA ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY PATIENT SATISFACTION & RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY PATIENT SATISFACTION & RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY PREDICTIVE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY PREDICTIVE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TREATMENT RECOMMENDATION ENGINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TREATMENT RECOMMENDATION ENGINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY ON-PREMISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 81. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 82. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 83. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 86. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 87. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 90. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 91. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 92. CANADA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 93. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 94. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 95. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 98. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 99. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 102. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 103. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 104. MEXICO PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 155. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 156. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 157. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 160. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 161. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 164. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 165. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 166. GERMANY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 167. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 168. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 169. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 172. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 173. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 176. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 177. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 178. FRANCE PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 191. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 192. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 193. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 196. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 197. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 200. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 201. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 202. ITALY PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 203. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 204. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 205. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 208. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 209. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 212. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 213. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 214. SPAIN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 251. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 252. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 253. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 256. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 257. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 260. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 261. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 262. DENMARK PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 275. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 276. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 277. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 280. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 281. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 284. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 285. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 286. QATAR PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 287. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 288. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 289. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 292. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 293. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 296. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 297. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 298. FINLAND PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN PERSONALIZED MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Personalized Medicine Software market report include:
  • 23andMe, Inc.
  • 3D Systems, Inc.
  • Caris Life Sciences, Inc.
  • Epic Systems Corporation
  • Flatiron Health, Inc.
  • Foundation Medicine, Inc.
  • Genelex Corporation
  • Genomind, Inc.
  • Health Fidelity, Inc.
  • IBM Corporation
  • Illumina, Inc.
  • Innowise
  • Invitae Corporation
  • NantHealth, Inc.
  • OSP Labs
  • Personal Genome Diagnostics, Inc.
  • Roche Holding AG
  • Strand Life Sciences Pvt. Ltd.
  • Syapse, Inc.
  • Tempus AI, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.51 billion
Forecasted Market Value ( USD ) by 2030 $ 4.23 billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Personalized Medicine Market by Product Type (Diagnostics, Therapeutics), Technology (Bioinformatics, Digital Health & AI, Genomics & Proteomics), Application, End User - Global Forecast 2025-2030 - Product Image

Personalized Medicine Market by Product Type (Diagnostics, Therapeutics), Technology (Bioinformatics, Digital Health & AI, Genomics & Proteomics), Application, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Report By Application (Early Detection, Treatment Selection, Monitoring), By Indication (Oncology, Neurology), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Report By Application (Early Detection, Treatment Selection, Monitoring), By Indication (Oncology, Neurology), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Hyper Personalized Medicines - Global Strategic Business Report - Product Image

Hyper Personalized Medicines - Global Strategic Business Report

  • Report
  • 390 Pages
  • Global
From
Personalized Medicine Biomarkers - Global Strategic Business Report - Product Image

Personalized Medicine Biomarkers - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.